Monday, August 4, 2008
Speed Raises Risks for Alzheimer’s Research
Posted by Shirley S. Wang in Wall Street Journal Health Blog
Drugmakers hurrying experimental Alzheimer’s drugs into late-stage testing may be undermining their ultimate chance at success.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment